UP!
| 2016-06-06 | Initiated Coverage | Goldman Sachs | Neutral | $14.00 |
| 2016-06-06 | Initiated Coverage | Goldman Sachs Group Inc. | Neutral | $14.00 |
| 2016-05-04 | Reiterated Rating | Leerink Swann | Outperform | $21.00 to $18.00 |
| 2016-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-05-04 | Reiterated Rating | Brean Capital | Buy | $19.00 |
| 2016-02-23 | Lower Price Target | Cowen and Company | $20.00 to $17.00 | |
| 2016-02-19 | Lower Price Target | Leerink Swann | Outperform | $22.00 to $21.00 |
| 2016-02-19 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $26.00 to $21.00 |
| 2016-02-19 | Reiterated Rating | Brean Capital | Buy | $29.00 to $19.00 |
| 2016-02-19 | Lower Price Target | Stifel Nicolaus | Buy | $29.00 to $20.00 |
| 2016-02-18 | Reiterated Rating | Maxim Group | Hold | |
| 2016-02-09 | Reiterated Rating | Stifel Nicolaus | Positive | |
| 2016-01-08 | Upgrade | Maxim Group | Sell to Hold | |
| 2015-12-29 | Reiterated Rating | Maxim Group | Sell | |
| 2015-12-22 | Reiterated Rating | Maxim Group | Sell | $7.00 |
| 2015-11-23 | Initiated Coverage | Barclays | Equal Weight | $22.00 |
| 2015-11-23 | Initiated Coverage | Barclays PLC | Equal Weight | $22.00 |
| 2015-11-13 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $26.00 |
| 2015-11-09 | Reiterated Rating | Cowen and Company | Hold | $23.00 to $20.00 |
| 2015-11-05 | Reiterated Rating | Leerink Swann | Buy | $25.00 to $22.00 |
| 2015-11-04 | Reiterated Rating | Brean Capital | Buy | $29.00 |
| 2015-10-26 | Reiterated Rating | Brean Capital | Buy | $31.00 to $29.00 |
| 2015-10-13 | Reiterated Rating | Leerink Swann | Outperform | $26.00 to $25.00 |
| 2015-10-05 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-08-24 | Reiterated Rating | Sanford C. Bernstein | Buy | |
| 2015-08-19 | Boost Price Target | Sanford C. Bernstein | Outperform | $25.00 to $31.00 |
| 2015-08-06 | Downgrade | Goldman Sachs | Buy to Neutral | $27.00 |
| 2015-08-05 | Reiterated Rating | Brean Capital | Buy | $31.00 |
| 2015-08-05 | Reiterated Rating | Cowen and Company | Hold | $18.00 to $23.00 |
| 2015-08-05 | Boost Price Target | Leerink Swann | Outperform | $25.00 to $26.00 |
| 2015-07-20 | Reiterated Rating | Brean Capital | Buy | $31.00 |
| 2015-06-26 | Reiterated Rating | Brean Capital | Buy | $31.00 |
| 2015-06-19 | Boost Price Target | Stifel Nicolaus | Buy | $26.00 to $29.00 |
| 2015-06-19 | Boost Price Target | Brean Capital | Buy | $25.00 to $31.00 |
| 2015-06-04 | Initiated Coverage | Stifel Nicolaus | Buy | $26.00 |
| 2015-05-18 | Reiterated Rating | Brean Capital | Buy | $25.00 |
| 2015-05-04 | Boost Price Target | Leerink Swann | Outperform | $24.00 to $25.00 |
| 2015-04-17 | Boost Price Target | Leerink Swann | Outperform | $16.00 to $24.00 |
| 2015-04-17 | Boost Price Target | Brean Capital | Buy | $15.00 to $25.00 |
| 2015-02-19 | Reiterated Rating | Brean Capital | Buy | $15.00 |
| 2015-02-17 | Set Price Target | Maxim Group | Sell | $7.00 |
| 2015-01-23 | Downgrade | Maxim Group | Buy to Sell | $17.00 to $7.00 |
| 2015-01-07 | Initiated Coverage | Brean Capital | Buy | $15.00 |
| 2014-06-05 | Initiated Coverage | Maxim Group | Buy | $24.00 to $17.00 |
| 2014-06-02 | Initiated Coverage | Goldman Sachs | Buy | $19.00 |
| 2014-05-09 | Initiated Coverage | Maxim Group | Buy | $24.00 |
| 2014-05-07 | Upgrade | Bank of America | Underperform to Buy | |
| 2014-05-07 | Reiterated Rating | Canaccord Genuity | Buy | $22.00 to $17.00 |
| 2013-11-05 | Boost Price Target | Sanford C. Bernstein | Outperform | $20.00 to $24.00 |
| 2013-10-14 | Initiated Coverage | R. F. Lafferty | Buy | $19.00 |
| 2013-06-18 | Initiated | WallachBeth | Buy | $17 |
| 2011-09-20 | Reiterated | Wedbush | Outperform | $29 to $24 |
| 2011-01-26 | Reiterated | Rodman & Renshaw | Mkt Outperform | $32 to $22 |
| 2010-11-02 | Reiterated | Oppenheimer | Outperform | $34 to $32 |
| 2010-08-26 | Reiterated | Rodman & Renshaw | Mkt Outperform | $24 to $32 |
| 2010-05-13 | Reiterated | Oppenheimer | Outperform | $17 to $19 |
| 2009-11-19 | Upgrade | Oppenheimer | Perform to Outperform | $15 |
| 2009-11-18 | Initiated | Canaccord Adams | Buy | |
| 2009-09-18 | Initiated | Deutsche Securities | Buy | $15 |
| 2009-05-19 | Initiated | Wedbush Morgan | Buy | $15 |
| 2009-02-13 | Upgrade | Stanford Research | Hold to Buy | $17 |
| 2009-01-05 | Initiated | Leerink Swann | Outperform | $16 |
| 2008-05-08 | Downgrade | Bear Stearns | Outperform to Peer Perform |
| 2016-06-06 | Initiated Coverage | Goldman Sachs | Neutral | $14.00 |
| 2016-06-06 | Initiated Coverage | Goldman Sachs Group Inc. | Neutral | $14.00 |
| 2016-05-04 | Reiterated Rating | Leerink Swann | Outperform | $21.00 to $18.00 |
| 2016-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-05-04 | Reiterated Rating | Brean Capital | Buy | $19.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MNTA 17 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 5.98M |
| Apex Capital Management | 1.94M |
| BlackRock Institutional Trust Company, N.A. | 1.72M |
| BlackRock Investment Management, LLC | 0.35M |
| TEACHERS ADVISORS INC | 0.31M |
| MANAGED ACCOUNT ADVISORS LLC | 0.25M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.17M |
| BlackRock Group LTD | 0.13M |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 40375 |
| BLACKROCK ADVISORS LLC | 33815 |
| KCG Holdings, Inc. | 25646 |
| CAPSTONE ASSET MANAGEMENT CO | 15773 |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 11673 |
| Alpine Partners USVI, LLC | 10580 |
| VTL Associates, LLC | 2461 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Kaundinya Ganesh Venkataraman Senior V.P., Research | 0.94% (495686) | MNTA / |
| WHEELER CRAIG A President | 0.64% (339645) | AVNR / FOLD / MNTA / |
| Leicher Bruce SVP & General Counsel | 0.32% (171194) | MNTA / |
| Roach James M. Senior VP, Development and Chi | 0.30% (157563) | MNTA / RTGN / |
| Bishop John E Senior VP, Pharmaceutical Scie | 0.30% (157253) | MNTA / |
| KWON YOUNG SVP, Corporate Development | 0.27% (141911) | MNTA / |
| Shea Richard P SVP, CFO | 0.23% (119906) | MNTA / SYBX / |
| Ottmer Matthew P. Chief Operating Officer | 0.14% (75000) | MNTA / |
| CLARKE JOHN K | 0.13% (69123) | ALNY / MNTA / VSTM / |
| Storer Scott M SVP, CFO | 0.08% (44783) | MNTA / |
| Franken Michael President, Biosimilars Busines | 0.07% (37968) | MNTA / RDUS / |
| Arroyo Santiago SVP, Chief Medical Officer | 0.07% (36000) | MNTA / |
| Stoner Elizabeth | 0.04% (22807) | MNTA / RDUS / |
| SULAT JAMES R | 0.04% (20500) | AMAG / MNTA / |
| DOWNEY BRUCE | 0.03% (15500) | CAH / MNTA / |
| Fanucci Marsha | 0.03% (14500) | ALNY / IRWD / MNTA / |
| Shapiro Bennett M | 0.02% (10834) | MNTA / |
| HUTT PETER BARTON | 0.01% (6725) | BIND / CNCE / IMMU / MNTA / XOMA / |
| Koestler Thomas P | 0.01% (5500) | MNTA / |
UM